ERBB3 and rectal cancer: Her3 overexpression was not associated with gender (OR = 1.03; 95% CI: 0.83–1.28; P = .79; Fig. 2D), age (OR = 0.96; 95% CI: 0.75–1.24; P = .77; Fig. 2E), and colon or rectum cancer (OR = 0.79; 95% CI: 0.44–1.43; P = .44; Fig. 2F).